Your browser doesn't support javascript.
loading
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer.
Dings, Mark P G; van der Zalm, Amber P; Bootsma, Sanne; van Maanen, Tatum F J; Waasdorp, Cynthia; van den Ende, Tom; Liu, Dajia; Bailey, Peter; Koster, Jan; Zwijnenburg, Danny A; Spek, C Arnold; Klomp, Jan P G; Oubrie, Arthur; Hooijer, Gerrit K J; Meijer, Sybren L; van Berge Henegouwen, Mark I; Hulshof, Maarten C; Bergman, Jacques; Oyarce, Cesar; Medema, Jan Paul; van Laarhoven, Hanneke W M; Bijlsma, Maarten F.
Afiliación
  • Dings MPG; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam,
  • van der Zalm AP; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands.
  • Bootsma S; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam,
  • van Maanen TFJ; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands.
  • Waasdorp C; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam,
  • van den Ende T; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands; Amsterdam UMC Location Univer
  • Liu D; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands; Amsterdam UMC Location Univer
  • Bailey P; School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Koster J; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands.
  • Zwijnenburg DA; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands.
  • Spek CA; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands.
  • Klomp JPG; Lead Pharma, Oss, the Netherlands.
  • Oubrie A; Lead Pharma, Oss, the Netherlands.
  • Hooijer GKJ; Amsterdam UMC Location University of Amsterdam, Department of Pathology, Amsterdam, the Netherlands.
  • Meijer SL; Amsterdam UMC Location University of Amsterdam, Department of Pathology, Amsterdam, the Netherlands.
  • van Berge Henegouwen MI; Amsterdam UMC Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
  • Hulshof MC; Amsterdam UMC Location University of Amsterdam, Department of Radiotherapy, Amsterdam, the Netherlands.
  • Bergman J; Amsterdam UMC Location University of Amsterdam, Department of Gastroenterology, Amsterdam, the Netherlands.
  • Oyarce C; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands; Amsterdam UMC Location Univer
  • Medema JP; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam,
  • van Laarhoven HWM; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands; Amsterdam UMC Location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands.
  • Bijlsma MF; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam,
Cell Rep Med ; 3(11): 100802, 2022 11 15.
Article en En | MEDLINE | ID: mdl-36334593

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biogénesis de Organelos / Neoplasias Esofágicas / Receptores de Estrógenos / Resistencia a Antineoplásicos / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biogénesis de Organelos / Neoplasias Esofágicas / Receptores de Estrógenos / Resistencia a Antineoplásicos / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article